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Chinese hamster ovary (CHO) cells, a major mammalian platform in biomanufacturing, produce and secret 
recombinant proteins along with host cell proteins (HCPs). Because residual HCPs in the final drug product can 
adversely affect (1) patients by causing immune responses, (2) drug efficacy, and (3) product stability, the 
effective removal of HCPs is necessary. Unfortunately, many studies have reported that many HCPs can be 
difficult to remove through downstream purification processes because they share similar biophysical properties 
to biopharmaceuticals. In this study we employed a genome engineering approach using clustered regularly 
interspaced short palindromic repeats and associated protein 9 (CRISPR/Cas9) system-mediated knockout to 
address difficult-to-remove HCP problems. Three HCPs (Cathepsin D, Nidogen-1, and Prosaposin) that are 
known to be difficult to remove were selected, and respective knockout clones were isolated without using 
selective reagents or reporter genes. Clones for each HCP were characterized using various analysis methods. 
Taken together, we demonstrate the applicability of the CRISPR/Cas9 system to eliminate difficult-to-remove 
HCP expression in an industry-relevant setting. 
 
